Statins, inflammation and deep vein thrombosis: a systematic review

[1]  K. Guire,et al.  Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  T. Wakefield,et al.  Interleukin-6: a potential target for post-thrombotic syndrome. , 2011, Annals of vascular surgery.

[3]  D. Rader,et al.  Short‐Term Treatment with High‐Dose Atorvastatin Reduces LDL Cholesterol but Shows no Anti‐Inflammatory Effects in Normolipidemic Subjects with Normal CRP Levels , 2010, Clinical and translational science.

[4]  G. Raskob,et al.  Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. , 2010, American Journal of Preventive Medicine.

[5]  M. Jougasaki,et al.  Statins suppress interleukin‐6‐induced monocyte chemo‐attractant protein‐1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells , 2010, British journal of pharmacology.

[6]  J. Bartholomew,et al.  Interpreting the Jupiter trial: Statins can prevent VTE, but more study is needed , 2010, Cleveland Clinic Journal of Medicine.

[7]  D. Khemasuwan,et al.  Statins decrease the occurrence of venous thromboembolism in patients with cancer. , 2010, The American journal of medicine.

[8]  P. Libby,et al.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism. , 2009, The New England journal of medicine.

[9]  F. Rosendaal,et al.  HMG‐CoA reductase inhibitors, other lipid‐lowering medication, antiplatelet therapy, and the risk of venous thrombosis , 2009, Journal of thrombosis and haemostasis : JTH.

[10]  M. den Heijer,et al.  Inflammation in deep vein thrombosis and the development of post‐thrombotic syndrome: a prospective study , 2009, Journal of thrombosis and haemostasis : JTH.

[11]  J. Heit,et al.  Incidence and cost burden of post-thrombotic syndrome , 2009, Journal of Thrombosis and Thrombolysis.

[12]  G. Pasterkamp,et al.  Unraveling Pleiotropic Effects Of Statins: Bit By Bit, a Slow Case With Perspective , 2008, Circulation research.

[13]  T. Wakefield,et al.  Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation , 2008, Thrombosis and Haemostasis.

[14]  M. Hori,et al.  Preprocedural statin administration can reduce thrombotic reaction after stent implantation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[15]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[16]  A. Monopoli,et al.  NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. , 2007, European journal of pharmacology.

[17]  A. Kaider,et al.  High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. , 2007, Clinical chemistry.

[18]  A. Kaider,et al.  Interleukin-6 and interleukin-6 promoter polymorphism (−174) G>C in patients with spontaneous venous thromboembolism , 2006, Thrombosis and Haemostasis.

[19]  Alberto Smith,et al.  Monocyte recruitment in venous thrombus resolution. , 2006, Journal of vascular surgery.

[20]  K. Bailey,et al.  Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study , 2005, Annals of Internal Medicine.

[21]  F. Mach,et al.  Statins Reduce Interleukin-6–Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  E. Minar,et al.  Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism , 2005, Thrombosis and Haemostasis.

[23]  E. Oger,et al.  Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital‐based case–control study , 2004, Fundamental & clinical pharmacology.

[24]  B. Psaty,et al.  HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women , 2004, Journal of thrombosis and haemostasis : JTH.

[25]  James Douketis,et al.  Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism , 2003, Annals of Internal Medicine.

[26]  A. Folsom,et al.  Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.

[27]  T. Kodama,et al.  The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. , 2002, Journal of atherosclerosis and thrombosis.

[28]  Michael R. Müller,et al.  Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[29]  M. den Heijer,et al.  Inflammatory response in the acute phase of deep vein thrombosis. , 2002, Journal of vascular surgery.

[30]  P. Monagle,et al.  Post-thrombotic syndrome , 2002, Archives of disease in childhood.

[31]  P. Reitsma,et al.  Interleukin 8 and venous thrombosis: evidence 
for a role of inflammation in thrombosis , 2002, British journal of haematology.

[32]  J. Musial,et al.  Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease. , 2002, Clinical laboratory.

[33]  N Rifai,et al.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. , 2001, JAMA.

[34]  J. Fowlkes,et al.  Interleukin-8 administration enhances venous thrombosis resolution in a rat model. , 2001, The Journal of surgical research.

[35]  A. Laupacis,et al.  Use of statins and the subsequent development of deep vein thrombosis. , 2001, Archives of internal medicine.

[36]  G. Avellone,et al.  Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response , 2000, European Journal of Clinical Pharmacology.

[37]  P. Reitsma,et al.  Recurrent Venous Thrombosis and Markers of Inflammation , 2000, Thrombosis and Haemostasis.

[38]  L. Greenfield,et al.  P-selectin and TNF inhibition reduce venous thrombosis inflammation. , 1996, The Journal of surgical research.

[39]  L. Greenfield,et al.  Inflammatory and Procoagulant Mediator Interactions in an Experimental Baboon Model of Venous Thrombosis , 1993, Thrombosis and Haemostasis.

[40]  E. Cooke,et al.  ABC OF VASCULAR DISEASES , 1992 .

[41]  J. Wolfe,et al.  ABC of vascular diseases. Deep venous insufficiency and occlusion. , 1992, BMJ.

[42]  Ackroyd Js,et al.  The investigation and surgery of the post-thrombotic syndrome. , 1986 .

[43]  N. Browse,et al.  The investigation and surgery of the post-thrombotic syndrome. , 1986, The Journal of cardiovascular surgery.